Age, race, and gender differences in antipsychotic medication use among children prior to entry to out-of-home care

Residential Treatment for Children and Youth

Volumn 26, Issue 2, 2009, Pages 119-134

  Robst, John ^a   Armstrong, Mary ^b   Dollard, Norin ^b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Antipsychotics; Disparities; Out of home treatment; Psychotropic medication

Indexed keywords

EID: 70449127532     PISSN: 0886571X     EISSN: 15410358     Source Type: Journal    
DOI: 10.1080/08865710902873026     Document Type: Article

References (29)

1. Aichhorn, W., Marksteiner, J., Walch, T., Zernig, G., Hinterhuber, H., Stuppaeck, C., et al. (2007). Age and gender effects on olanzapine and risperidone plasma concentrations in children and adolescents. Journal of Child and Adolescent Psychopharmacology, 17, 665-674.
2. Aparasu, R. R., & Bhatara, V. (2007). Patterns and determinants of antipsychotic prescribing in children and adolescents, 2003-2004. Current Medical Research and Opinion, 23, 49-56.
3. Armstrong, M. I., Dhont, K., Kane, M., Langlois, J., Larkins, M. R., Matos, J., et al. (2005). Evaluation of the State Inpatient Psychiatric Program (SIPP) for FY 2004-2005. Florida Mental Health Institute: Tampa, FL.
4. Baker, A. J. L., Kurland, D., Curtis, P., Alexander, G., & Papa-Lentini, C. (2007). Mental health and behavioral problems of youth in the child welfare system: Residential treatment centers compared to therapeutic foster care in the Odyssey Project population. Child Welfare, 86, 97-123.
5. Breland-Noble, A. M., Elbogen, E. B., Farmer, E., Dubs, M. S., Wagner, H. R., & Burns, B. J. (2004). Use of psychotropic medications by youths in therapeutic foster care and group homes. Psychiatric Services, 55, 706-708.
6. Chamberlain, P., & Reid, J. B. (1994). Differences in risk factors and adjustment for male and female delinquents in treatment foster care. Journal of Child and Family Studies, 3, 23-39.
7. Cheng-Shannon, J., McGough, J. J., Pataki, C., & McCracken, J. T. (2004). Second generation antipsychotic medications in children and adolescents. Journal of Child and Adolescent Psychopharmacology, 14, 372-394.
8. Constantine, R. & Tandon, R. (2008). Changing trends in pediatric antipsychotic use in Florida's Medicaid program. Psychiatric Services, 59, 1162-1168.
9. Cooper, W. O., Arbogast, P. G., Ding, H., Hickson, G. B., Fuchs, D. C., & Ray, W. A. (2006). Trends in prescribing of antipsychotic medications for U.S. children. Ambulatory Pediatrics, 6, 79-83.
10. Cooper, W. O., Hickson, G. B., Fuchs, D. C ., Arbogast, P. G., & Ray, W. A. (2004). New users of antipsychotic medications among children enrolled in TennCare. Archives of Pediatrics and Adolescent Medicine, 158, 753-759.
11. Farmer, E. M. Z., Wagner, H. R., Burns, B. J., & Richards, J. T. (2003). Treatment foster care in a system of care: Sequences and correlates of residential placements. Journal of Child and Family Studies, 12, 11-25.
12. Gianfrancesco, F. D., Grogg, A. L., Mahmoud, R. A., Wang, R. H., & Nasrallah, H. A. (2002). Differential effects of risperidone, olanzapine, clozapine, and conventional antipsychotics on type 2 diabetes: Findings from a large health plan database. Journal of Clinical Psychiatry, 63, 920-930.
13. Gersing, K., Burchett, B., March, J., Ostbye, T., & Krishnan, K. R. (2007). Predicting antipsychotic use in children. Psychopharmacology Bulletin, 40, 116-124.
14. Hardin, J., & Hilbe J. (2002). Generalized Estimating Equations. Danvers, MA: CRC Press.
15. Harrison-Woolrych, M., Garcia-Quiroga, J., Ashton, J., & Herbison, P. (2007). Safety and usage of atypical antipsychotic medicines in children: A nationwide prospective cohort study. Drug Safety, 30, 569-579.
16. Jerrell, J. M., & McIntyre, R. S. (2008). Adverse events in children and adolescents treated with antipsychotic medications. Human Psychopharmacology, 23, 283-290.
17. Kuno, E., & Rothbard, A. B. (2002). Racial disparities in antipsychotic prescription patterns for patients with schizophrenia. American Journal of Psychiatry, 159, 567-572.
18. Lyons, J. S., MacIntyre, J. C., Lee, M. E., Carpinello, S., Zuber, M. P., & Fazio, M. L. (2004). Psychotropic medications prescribing patterns for children and adolescents in New York's public mental health system. Community Mental Health Journal, 40, 101-117.
19. Martin, A., VanHoof, T., Stubbe, D., Sherwin, T., & Scahill, L. (2003). Multiple psychotropic pharmacology among children and adolescent enrollees in Connecticut Medicaid managed care. Psychiatric Services, 54, 72-77.
20. Medicaid Drug Therapy Management Program for Behavioral Health. Florida Best Practice Psychotherapeutic Guidelines for Children and Adolescents. Louis de la parte Florida Mental Health Institute, University of South Florida. Retrieved March 1, 2008, from http://flmedicaidbh.fmhi.usf.edu/recommended- child-guidelines.htm
21. Najjar, F., Welch, C., Grapentine, W. L., Sachs, H., Sinischalchi, J. & Price, L. H. (2004). Trends in psychotropic drug use in a child psychiatric hospital from 1991-1998. Journal of Child & Adolescent Psychopharmacology, 14, 87-93.
22. Olfson, M., Blanco, C., Liu, L., Moreno, C., & Laje, G. (2006). National trends in the outpatient treatment of children and adolescents with antipsychotic drugs. Archives of general Psychiatry, 63, 679-685.
23. Patel, N. C., Sanchez, R. J., Johnsrud, M. T., & Crismon, M. L. (2002). Trends in antipsychotic use in a Texas Medicaid population of children and adolescents: 1996 to 2000. Journal of Child and Adolescent Psychopharmacology, 12, 221-229.
24. Raedler, T. J., Schreiner, A., Naber, D., & Wiedemann, K. (2006). Gender-specific effects in the treatment of acute schizophrenia with risperidone. Pharmacopsychiatry, 39, 171-174. (Pubitemid 44369176)
25. Rawal, P. H., Lyons, J. S., MacIntyre II, J. C., & Hunter, J. C., (2004). Regional variation and clinical indicators of antipsychotic use in residential treatment: A fourstate comparison. Journal of Behavioral Health Services & Research, 31, 178-188.
26. Seeman, M. V. (2004) Gender differences in the prescribing of antipsychotic drugs. American Journal of Psychiatry, 161, 1324-1333.
27. Usall, J., Suarez, D., & Haro, J. M. (2007). Gender differences in response to antipsychotic treatment in outpatients with schizophrenia. Psychiatry Research, 153, 225-231.
28. Van Dorn, R. A., Swanson, J. W., Swartz, M. S., & Elbogen, E. B. (2005). The effects of race and criminal justice involvement on access to atypical antipsychotic medications among persons with schizophrenia. Mental Health Services Research, 7, 123-134.
29. Zito, J. M., Safer, D. J., Sai, D., Gardner, J. F., Thomas, D., Coombes, P., et al. (2008). Psychotropic medication patterns among youth in foster care. Pediatrics, 121, 157-163.